Breaking News Instant updates and real-time market news.

DVMT

Dell Technologies

$94.38

0.67 (0.71%)

, VMW

VMware

$155.50

0.66 (0.43%)

18:33
07/10/18
07/10
18:33
07/10/18
18:33

Shareholders have misgivings about Dell offer, may oppose it, WSJ reports

Shareholders of at least 10% of Dell Technologies (DVMT), which tracks Dell's controlling stake in VMware (VMW), have misgivings with terms of a bid to buy them out and may oppose it, the Wall Street Journal reports, citing people familiar with the matter. The holders include several teams at BlackRock (BLK) as well as Farallon Capital and Canyon Capital, the report notes. Dell is offering DVMT stakeholders $109 per share in cash and stock, the report notes. Reference Link

DVMT

Dell Technologies

$94.38

0.67 (0.71%)

VMW

VMware

$155.50

0.66 (0.43%)

BLK

BlackRock

$504.68

0.53 (0.11%)

  • 10

    Jul

  • 12

    Jul

  • 16

    Jul

  • 08

    Aug

DVMT Dell Technologies
$94.38

0.67 (0.71%)

07/03/18
DBAB
07/03/18
NO CHANGE
Target $190
DBAB
Buy
VMware shares have multiple expansion upside, says Deutsche Bank
Deutsche Bank analyst Karl Keirstead believes shares of VMware (VMW) have multiple expansion upside now that the "Dell event risk is largely behind us." The analyst raised his price target for VMware shares to $190 from $185 and keeps a Buy rating on the name in a research note titled "An Early Independence Day."
07/03/18
LEHM
07/03/18
NO CHANGE
Target $172
LEHM
Overweight
VMware price target raised to $172 from $160 at Barclays
Barclays analyst Raimo Lenschow raised his price target for VMware to $172 saying yesterday's announcements around Dell's acquisition of Dell Technologies (DVMT) "will remove a significant overhang." Potential long-only investors were staying on the sidelines due to uncertainty around Dell's review of strategic alternatives, Lenschow tells investors in a research note. Dell's transaction implies that VMware will remain an independent entity, at least in the mid term, which should bring the "attractive fundamentals back in focus," the analyst contends. He reiterates an Overweight rating on VMware.
07/03/18
WELS
07/03/18
NO CHANGE
Target $105
WELS
Outperform
Dell Technologies price target raised to $105 from $92.50 at Wells Fargo
Wells Fargo analyst Philip Winslow raised his price target for Dell Technologies to $105 from $92.50 after the company announced the acquisition of Class V common stock in a negotiated conversion into shares of Class C common stock with a cash election option up to an aggregate amount of $9B. The analyst reiterates an Outperform rating on the shares.
07/10/18
WELS
07/10/18
NO CHANGE
Target $155
WELS
Market Perform
VMware price target raised to $155 from $135 at Wells Fargo
Wells Fargo analyst Phil Winslow raised his price target for VMware (VMW) to $155 from $135 to account for the one-time special dividend and guidance announced in conjunction with Dell Technologies' acquisition of Class V common stock (DVMT) on July 2, 2018. The analyst reiterates a Market Perform rating on VMware's shares.
VMW VMware
$155.50

0.66 (0.43%)

07/03/18
BMOC
07/03/18
NO CHANGE
Target $175
BMOC
Outperform
VMware price target raised to $175 from $155 at BMO Capital
BMO Capital analyst Keith Bachman raised his price target on VMware to $175, saying the company's announcement of a special dividend to "fund Dell" was one of the "least offensive solutions" as it removes near-term concerns about a reverse merger, even though he preferred that the capital was invested in its business. Bachman further notes that the deal will ease some of VMWare's employee attrition, but believes that Dell will still eventually buy VMWare. The analyst keeps his Outperform rating on the shares.
BLK BlackRock
$504.68

0.53 (0.11%)

01/25/18
01/25/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Discover (DFS) downgraded to In Line from Outperform at Evercore ISI. 2. BlackRock (BLK) downgraded to Neutral from Buy at Citi with analyst William Katz saying the "revaluation thesis" is now well understood. 3. bluebird bio (BLUE) downgraded to Market Perform from Outperform at Leerink with analyst Michael Schmidt saying the company's clinical stage pipeline now is fairly valued while visibility into additional near-term sources of upside is limited. 4. Jagged Peak Energy (JAG) downgraded to Sector Perform from Outperform at RBC Capital with analyst Scott Hanold citing a tight frac service market in the Permian that lowers his projected growth outlook, saying the company is "more susceptible to frac service constraints due to its smaller scale and being a relatively newer entrant." 5. Varian Medical (VAR) downgraded to Sell from Neutral at Goldman Sachs with analyst Isaac Ro saying shares offer poor risk/reward versus MedTech peers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/05/18
FBCO
04/05/18
NO CHANGE
Target $678
FBCO
Outperform
BlackRock price target raised to $678 from $672 at Credit Suisse
Credit Suisse analyst Craig Siegenthaler raised his price target for BlackRock to $678 from $672 on valuation. The analyst reiterates an Outperform rating on the shares.
06/18/18
SBSH
06/18/18
UPGRADE
Target $610
SBSH
Buy
BlackRock upgraded to Buy from Neutral at Citi
Citi analyst William Katz upgraded BlackRock to Buy and raised his price target for the shares to $610 from $590. The company is "well positioned against shifting industry ecosystems, far ahead of key peers," and should sustain about 5% per annum organic growth while increasing margins, Katz tells investors in a research note. He believes BlackRock's competitive moat is widening, which should support the stock's premium valuation.
07/02/18
JPMS
07/02/18
NO CHANGE
Target $547
JPMS
Overweight
BlackRock removed from Analyst Focus List at JPMorgan
JPMorgan analyst Kenneth Worthington removed BlackRock from his firm's Analyst Focus List and lowered his price target for the shares to $547 from $618. The analyst sees the macro environment as "less constructive" for BlackRock near term. Divergent beta trends have turned negative in recent months with both non-U.S. currencies and non-U.S. markets underperforming, Worthington tells investors in a research note. The analyst, however, continues to believe longer term secular trends are strong for iShares and keeps an Overweight rating on BlackRock.

TODAY'S FREE FLY STORIES

LYV

Live Nation

$51.24

-0.305 (-0.59%)

07:48
07/17/18
07/17
07:48
07/17/18
07:48
Downgrade
Live Nation rating change  »

Live Nation downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COCP

Cocrystal Pharma

$4.35

0.01 (0.23%)

07:48
07/17/18
07/17
07:48
07/17/18
07:48
Initiation
Cocrystal Pharma initiated  »

Cocrystal Pharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$248.21

-1.11 (-0.45%)

, AMD

AMD

$16.58

0.305 (1.87%)

07:48
07/17/18
07/17
07:48
07/17/18
07:48
Recommendations
Nvidia, AMD analyst commentary  »

Negative gaming data for…

NVDA

Nvidia

$248.21

-1.11 (-0.45%)

AMD

AMD

$16.58

0.305 (1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 07

    Aug

AGRO

Adecogro

$8.41

0.05 (0.60%)

07:47
07/17/18
07/17
07:47
07/17/18
07:47
Initiation
Adecogro initiated  »

Adecogro initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$400.24

4.32 (1.09%)

07:46
07/17/18
07/17
07:46
07/17/18
07:46
Technical Analysis
Technical Take: Netflix off worst post-earnings levels in early trading »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACRS

Aclaris Therapeutics

$20.49

-0.11 (-0.53%)

, LLY

Eli Lilly

$89.06

-0.64 (-0.71%)

07:45
07/17/18
07/17
07:45
07/17/18
07:45
Recommendations
Aclaris Therapeutics, Eli Lilly, Pfizer analyst commentary  »

Aclaris offers best…

ACRS

Aclaris Therapeutics

$20.49

-0.11 (-0.53%)

LLY

Eli Lilly

$89.06

-0.64 (-0.71%)

PFE

Pfizer

$37.39

-0.14 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 22

    Aug

  • 10

    Sep

NEWR

New Relic

$109.01

0.35 (0.32%)

07:39
07/17/18
07/17
07:39
07/17/18
07:39
Initiation
New Relic initiated  »

New Relic initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

GS

Goldman Sachs

$231.01

4.71 (2.08%)

07:38
07/17/18
07/17
07:38
07/17/18
07:38
Hot Stocks
Goldman Sachs reports Q2 FICC revenue $1.68B, 45% higher than last year »

Net revenues in Fixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IQ

iQIYI

$36.92

3 (8.84%)

07:38
07/17/18
07/17
07:38
07/17/18
07:38
Technical Analysis
Technical Take: iQIYI falls, completes Skymoons acquisition »

The shares of iQIYI (IQ)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCR

Novocure

$35.60

2.5 (7.55%)

07:37
07/17/18
07/17
07:37
07/17/18
07:37
Hot Stocks
Novocure announces scientific track for tumor treating fields at EMBS »

Novocure announced that a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

RVI

Retail Value

$35.60

-0.36 (-1.00%)

, DDR

DDR Corp.

$14.31

-0.045 (-0.31%)

07:36
07/17/18
07/17
07:36
07/17/18
07:36
Initiation
Retail Value, DDR Corp. initiated  »

Retail Value initiated…

RVI

Retail Value

$35.60

-0.36 (-1.00%)

DDR

DDR Corp.

$14.31

-0.045 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GS

Goldman Sachs

$231.01

4.71 (2.08%)

07:36
07/17/18
07/17
07:36
07/17/18
07:36
Hot Stocks
Goldman Sachs reports Q2 annualized ROE 12.8% »

Annualized return on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XXII

22nd Century

$2.64

-0.12 (-4.35%)

07:35
07/17/18
07/17
07:35
07/17/18
07:35
Hot Stocks
22nd Century comments on FDA's ANPRM to lessen nicotine in cigarettes »

22nd Century responded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$400.24

4.32 (1.09%)

, MSFT

Microsoft

$104.91

-0.51 (-0.48%)

07:35
07/17/18
07/17
07:35
07/17/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

NFLX

Netflix

$400.24

4.32 (1.09%)

MSFT

Microsoft

$104.91

-0.51 (-0.48%)

SNAP

Snap

$13.07

-0.295 (-2.21%)

FOXA

21st Century Fox

$46.71

-0.84 (-1.77%)

MS

Morgan Stanley

$48.91

0.85 (1.77%)

TGT

Target

$77.20

-0.525 (-0.68%)

FSLR

First Solar

$53.99

-0.08 (-0.15%)

CZR

Caesars

$11.63

0.075 (0.65%)

FTI

TechnipFMC

$30.58

-0.36 (-1.16%)

HFC

HollyFrontier

$68.91

0.25 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

  • 18

    Jul

  • 19

    Jul

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 02

    Aug

  • 07

    Aug

  • 08

    Aug

  • 08

    Aug

  • 04

    Sep

BCRX

BioCryst

$6.20

0.01 (0.16%)

07:34
07/17/18
07/17
07:34
07/17/18
07:34
Upgrade
BioCryst rating change  »

BioCryst upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$231.01

4.71 (2.08%)

07:33
07/17/18
07/17
07:33
07/17/18
07:33
Earnings
Goldman Sachs reports Q2 EPS $5.98, consensus $4.66 »

Reports Q2 revenue $9.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADS

Alliance Data

$218.91

-24.58 (-10.09%)

, LB

L Brands

$32.01

0.31 (0.98%)

07:32
07/17/18
07/17
07:32
07/17/18
07:32
Hot Stocks
Columbus signs renewal agreement with Victoria's Secret »

Alliance Data Systems…

ADS

Alliance Data

$218.91

-24.58 (-10.09%)

LB

L Brands

$32.01

0.31 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 08

    Aug

PRIM

Primoris

$28.12

-0.51 (-1.78%)

07:32
07/17/18
07/17
07:32
07/17/18
07:32
Hot Stocks
Primoris announces electrical distribution award valued over $75M »

Primoris Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZS

Zscaler

$41.10

1.38 (3.47%)

07:30
07/17/18
07/17
07:30
07/17/18
07:30
Recommendations
Zscaler analyst commentary  »

Zscaler price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$40.55

-4.34 (-9.67%)

, QEP

QEP Resources

$12.09

-0.67 (-5.25%)

07:30
07/17/18
07/17
07:30
07/17/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

TSRO

Tesaro

$40.55

-4.34 (-9.67%)

QEP

QEP Resources

$12.09

-0.67 (-5.25%)

HUBG

Hub Group

$49.10

-1.85 (-3.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 19

    Aug

RPM

RPM

$60.00

-0.54 (-0.89%)

07:27
07/17/18
07/17
07:27
07/17/18
07:27
Downgrade
RPM rating change  »

RPM downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

OSUR

OraSure

$16.28

-1.04 (-6.00%)

07:27
07/17/18
07/17
07:27
07/17/18
07:27
Recommendations
OraSure analyst commentary  »

OraSure weakness a buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 08

    Aug

NFLX

Netflix

$400.24

4.32 (1.09%)

07:26
07/17/18
07/17
07:26
07/17/18
07:26
Recommendations
Netflix analyst commentary  »

Canaccord views Netflix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECOR

ElectroCore

$14.49

-0.51 (-3.40%)

07:25
07/17/18
07/17
07:25
07/17/18
07:25
Initiation
ElectroCore initiated  »

ElectroCore initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$30.58

-0.36 (-1.16%)

07:24
07/17/18
07/17
07:24
07/17/18
07:24
Initiation
TechnipFMC initiated  »

TechnipFMC assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.